Universal framework is 'crucial next step' for involving patients in drug development
This article was originally published in SRA
Executive Summary
Regulators, industry and other drug stakeholders across the globe are being called on to join a new initiative to develop the first universal framework for systematically involving patients in drug development, regulatory review and market access decisions.